Back to BlackRock, Inc. BlackRock, Inc.

IMNMIMNM
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in IMMUNOME INC

Yes. BlackRock holds 8,805,492 shares of IMNM (Immunome), worth $186.6M, as of its Q2 2026 13F filing. It increased the position by 636,818 shares (+7.8%) from Q1 2026. BlackRock has held IMNM in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$186.6M

Current Shares

8.8M

Total Value Change

+$128.4M

Total Shares Change

+4.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
8.8M
+7.8%
$186.6M0.0%$21.19
33
2026-Q1
Increased
8.2M
+7.5%
$178.6M0.0%$21.87
33
2025-Q4
Increased
7.6M
+30.4%
$163.1M0.0%$21.48
38
2025-Q3
Increased
5.8M
+0.9%
$68.2M0.0%$11.71
30
2025-Q2
Increased
5.8M
+1.9%
$53.7M0.0%$9.30
30
2025-Q1
Increased
5.7M
+37.3%
$38.1M0.0%$6.73
38
2024-Q4
Increased
4.1M
+3.6%
$43.8M0.0%$10.62
30
2024-Q3
First report
4M
-
$58.2M0.0%$14.62
0

Other major holders of IMNM: FMR LLC, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used